Lv4
560 积分 2024-12-22 加入
Effect of sodium-glucose cotransporter-2 inhibitors on kidney outcomes of individuals with type 2 diabetes according to blood pressure levels
13天前
已完结
Sex Differences in the Association Between Thyroid Hormone Sensitivity and Cardiovascular-Kidney-Metabolic Syndrome
1个月前
已完结
Cardiovascular-kidney-metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD
1个月前
已关闭
Disclosures: Standards of Care in Diabetes—2026
2个月前
已完结
Beyond Discrete Diagnoses: Conceptualizing Obesity-associated Metabolic Disorders as a Unified, Dynamic Continuum
3个月前
已完结
Metabolically healthy obesity: from epidemiology and mechanisms to clinical implications
4个月前
已完结
Glucagon‐like peptide‐1 receptor agonist treatment associated weight fluctuation and influencing factors in patients with overweight or obesity
7个月前
已完结
皖公网安备34019202002308
